Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Nov 14;7(21):6705-6706.
doi: 10.1182/bloodadvances.2023011103.

Should we move to a genomic classification of neutrophilic myeloid neoplasms?

Gonzalo Carreño-Tarragona  1 , Alberto Álvarez-Larrán  2 , Juan Carlos Hernández-Boluda  3 , Rosa Ayala  1 , Nicholas C P Cross  4   5
Affiliations
Comment

Should we move to a genomic classification of neutrophilic myeloid neoplasms?

Gonzalo Carreño-Tarragona et al. Blood Adv. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: The authors declare no competing financial interests.

Comment on

References

    1. Tremblay D, Sinai M, States U, et al. CNL and aCML are prognostically distinct: a large National Cancer Database analysis. Blood Adv. 2023;7:4400–4402. - PMC - PubMed
    1. Carreño-Tarragona G, Alvarez-Larran A, Harrison CN, et al. CNL and aCML should be considered as single entity based on molecular profiles and outcomes. Blood Adv. 2023;7(9):1672–1681. - PMC - PubMed
    1. Khoury JD, Solary E, Abla O, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia. 2022;36(7):1703–1719. - PMC - PubMed
    1. Elliott MA, Hanson CA, Dewald GW, Smoley SA, Lasho TL, Tefferi A. WHO-defined chronic neutrophilic leukemia: a long-term analysis of 12 cases and a critical review of the literature [12] Leukemia. 2005;19(2):313–317. - PubMed
    1. Patnaik MM, Tefferi A. Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management. Am J Hematol. 2023;98(4):681–689. - PubMed